Revelation Biosciences Inc.

05/23/2022 | Press release | Distributed by Public on 05/23/2022 09:35

Revelation Biosciences Inc. Announces Safety Monitoring Committee Recommendation for Continuing Evaluation of REVTx-99b for the Treatment of Allergic Rhinitis